Kala Bio

(NASDAQ) KALA

Current Price$3.08

Market Cap$2.90B

Since IPO (2017)-100%

5 Year-100%

1 Year-98%

1 Month-69%

Kala Bio Financials at a Glance

Market Cap

$2.90B

Revenue (TTM)

$0.00

Net Income (TTM)

$26.98M

EPS (TTM)

$-208.60

P/E Ratio

-0.01

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Price

$3.08

Volume

1,894

Open

$2.92

Price

$3.08

Volume

1,894

Open

$2.92

Previous Close

$3.12

Daily Range

$2.92 - $3.09

52-Week Range

$2.85 - $1030.00

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Price

$3.08

Volume

1,894

Open

$2.92

Previous Close

$3.12

Daily Range

$2.92 - $3.09

52-Week Range

$2.85 - $1030.00

KALA News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Kala Bio

Industry

Biotechnology

Sector

Health Care

Employees

CEO

David Elliot Lazar

Website

www.kalarx.com

Headquarters

Arlington, MA 02476, US

KALA Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-279%

Return on Capital

-6%

Return on Assets

-3%

Earnings Yield

-100.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.90B

Shares Outstanding

929.49M

Volume

1.89K

Avg. Volume

164.15K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$39.16M

EBITDA

$23.39M

Operating Cash Flow

$31.99M

Capital Expenditure

$15.00K

Free Cash Flow

$31.99M

Cash & ST Invst.

$7.56M

Total Debt

$0.00

Kala Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$54.00K

+21.7%

Gross Margin

0.00%

N/A

Market Cap

$2.90B

N/A

Market Cap/Employee

$76.32M

N/A

Employees

N/A

Net Income

$686.00K

+108.4%

EBITDA

$10.17M

-8.3%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$7.56M

-60.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-2.84%

N/A

Return on Invested Capital

-5.60%

N/A

Free Cash Flow

$4.57M

+2.0%

Operating Cash Flow

$4.56M

+0.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VYNEVYNE Therapeutics Inc.

VYNEVYNE Therapeutics Inc.$0.67+1.67%

XTLBXTL Biopharmaceuticals Ltd.

XTLBXTL Biopharmaceuticals Ltd.$2.65+1.53%

KTTAPasithea Therapeutics Corp.

KTTAPasithea Therapeutics Corp.$0.77-0.81%

SNGXSoligenix, Inc.

SNGXSoligenix, Inc.$0.36+16.27%

ENSCEnsysce Biosciences, Inc.

ENSCEnsysce Biosciences, Inc.$0.30-5.66%

ABPAbpro Corporation

ABPAbpro Corporation$0.52+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$17.07+0.07%

EOSEEos Energy Enterprises

EOSEEos Energy Enterprises$8.94+0.10%

NOKNokia

NOKNokia$14.19+0.08%

VNETVnet Group

VNETVnet Group$11.34+0.26%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.50-0.02%

POETPoet Technologies

POETPoet Technologies$13.90+0.01%

QUBTQuantum Computing

QUBTQuantum Computing$11.15-0.05%

Questions About KALA

What is the current price of Kala Bio?

Kala Bio is trading at $3.08 per share.

What is the 52-week range for Kala Bio?

Over the past 52 weeks, Kala Bio has traded between $2.85 and $1,030.00.

How much debt does Kala Bio have?

As of the most recent reporting period, Kala Bio reported total debt of N/A.

How much cash does Kala Bio have on hand?

Kala Bio reported $7.56M in cash and cash equivalents in its most recent financial results.

What is Kala Bio’s dividend yield?

Kala Bio does not currently have a dividend yield.

Kala Bio

Kala Bio Financials at a Glance

KALA News

Kala Bio (KALA) Q2 Loss Widens 15%

Why Kala Pharmaceuticals Stock Sank Today

Keep Your Eye on These 4 Healthcare Stocks

How Medical Billing Coverage Spells Success Or Failure For Drugmakers

Kala Pharmaceuticals Reports Disappointing Q2 Sales

Here's Why Kala Pharmaceuticals Fell as Much as 17.7% Today

Here's Why Kala Pharmaceuticals Got Crushed on Friday

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Kala Bio

KALA Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Kala Bio Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About KALA

What is the current price of Kala Bio?

What is the 52-week range for Kala Bio?

How much debt does Kala Bio have?

How much cash does Kala Bio have on hand?

What is Kala Bio’s dividend yield?

Premium Investing Services